Prime editor vPE reduces indel errors and improves editing efficiency in human cell lines
Background
A News article in Molecular Therapy Nucleic Acids reports that prime editor vPE reduced insertion and deletion errors (indels) and improved editing efficiency compared with PEmax in human cell lines. The article discusses research by Chauhan and colleagues. It does not report complete elimination of errors and is not a clinical study reporting therapeutic benefits in patients.
Prime editing introduces desired genomic changes without cutting both DNA strands or supplying a separate repair template. It can be designed for base substitutions and small insertions or deletions, but not every intended change becomes stably established. This is because the 5′ DNA flap, which retains the pre-editing information, competes with the 3′ DNA flap, which carries the new editing information. A flap is a protruding DNA strand formed during editing. Indels can also arise alongside the intended edit.
Key findings
According to the News article, the researchers explored Cas9 variants that allow greater flexibility in the position of a nick, a cut in one DNA strand. The approach aims to destabilize the unedited 5′ end and promote its degradation so that the intended edit is retained. Among the selected variants, R976A and H982A were associated with pronounced destabilization of the 5′ end.
The development process revealed a trade-off between accuracy and efficiency. The article reports that pPE, combining K848A and H982A, reduced indel errors by a factor of up to 36 and improved the ratio of intended edits to indels by up to 28-fold. However, its editing efficiency was lower than that of PEmax. These figures are for the intermediate construct pPE and do not represent the effect size of the final vPE.
The researchers added mutations that increase Cas9 activity to create xPE. Editing efficiency with xPE increased compared with pPE, but remained below that of PEmax. They then combined the Cas9 mutation design from xPE with PE7. PE7 is designed to stabilize prime editing guide RNA (pegRNA) by incorporating the polyuridine (poly-U) RNA-binding function of the La protein. The resulting vPE was reported to have fewer indel errors and higher editing efficiency than PEmax. The News article also describes evaluation in several mammalian cell lines, but the provided material gives no target-specific effect sizes for vPE or detailed figures by cell line.
Implications and outlook
The central design aim of vPE is to increase intended edits while reducing unwanted indels. Evaluating a tool only by editing efficiency can overlook accompanying errors. The development process illustrates why editing efficiency and the ratio of intended edits to indels should be considered together.
Potential applications should be distinguished from the experimental results. The validation scope stated in the provided News article is human cell lines; treatment of genetic diseases and crop improvement are directions for future research. There is also insufficient evidence to interpret reduced indels as reduced genome-wide off-target activity or as proof of safety. Patient benefit, in vivo delivery and safety, and editing performance in crops cannot be established from this material. Further validation for specific targets and conditions is needed to assess practical applications.
Source: Full text of the News article describing vPE design and results, DOI: 10.1016/j.omtn.2026.102898.
Prime editing is a precise "search and replace" genome editing tool that enables programmed genome modifications without the need for double-stranded breaks or additional repair templates. However, the retention of the unedited 5' strand hinders the incorporation of stable edits into the genome, and the rate of indel errors is also high. Recently,
Laboratories studying genetic-variant correction need to compare how often the intended edit occurs with how often indels arise. For example, when evaluating PEmax and vPE at the same correction target, researchers can measure editing efficiency and the ratio of intended edits to indels together to choose a tool for follow-up experiments. vPE is a candidate design intended to improve both measures. However, the evidence provided comes from a News article discussing the original research, so the targets, cell conditions, and detailed data in the original study should be checked before adopting it. These results alone cannot establish therapeutic safety or patient benefit, and agricultural applications also require separate validation in crops.